Each year the Arizona Bioindustry Association, Inc. shines a spotlight on three Arizona life science companies that have achieved outstanding milestones in the past 18 months. In 2024, Nectero Medical, Inc., PriZm Therapeutics, and The Patient Company are being honored with AZBio Fast Lane Awards on September 18, 2024 at the 20th annual AZBio Awards. Continue reading
Author Archive: AZBio
Mixed Perspectives on the 2 year anniversary of the Inflation Reduction Act
August 16, 2024, marks the 2 year anniversary of the Inflation Reduction Act (IRA). One of the most talked about and written about policies of the current administration, The IRA has far reaching impacts. Whether they are positive or negative is a matter of perspective.Continue reading
Exploring Pathways to Bioscience and Healthcare Careers during AZBW 2024
Attention Teachers! Are you looking for free, engaging, on-demand resources to inspire your students with the possibilities in Arizona’s Bioscience and Healthcare industries? Thanks to the Exploring Pathways to Bioscience and Healthcare Careers grant, and support by the Flinn Foundation and the Office of the Maricopa County School Superintendent we have new resources for you and your students to enjoy during and after Arizona Bioscience Week.Continue reading
Flambeau Medical is Growing in Phoenix
Flambeau Medical, a full-service, contract manufacturing organization serving the medical device and life science industries is growing in Phoenix. The company provides a full suite of development and manufacturing capabilities in FDA registered and ISO-13485:2016 certified manufacturing operations.Continue reading
Suresh Garimella to become the 23rd president of the University of Arizona
The Arizona Board of Regents has appointed Suresh Garimella as the 23rd president of the University of Arizona.Continue reading
CMS Publishes Final TCET Rule to Guide Medtech Innovators
In June of 2023, the comment period for the proposed rule on Transitional Coverage for Emerging Technologies (TCET) through the national coverage determination (NCD) process under the Social Security Act closed. The draft rule has been released for public inspection and the final rule will be published on August 12, 2024.Continue reading
Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the successful completion of its WAVE pre-clinical trial. The Accelerate WAVE system is designed to deliver rapid antimicrobial susceptibility testing (“AST”) directly from positive blood culture (“PBC”) bottles and bacterial isolated colonies (“Isolates”) to report accurate results within 4.5 hours, on average.Continue reading
Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine
LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ – Anivive Lifesciences Inc, a One Health technology company today announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded Anivive a new contract (#75N93024C00009) worth up to $33M to support the development of a vaccine against the fungus Coccidioides, which causes Valley Fever.Continue reading
AZMN Founders to Receive the 2024 AZBio Service Award
Jack and Barbara Kavanagh, founders of the Arizona Myeloma Network and Cancer Caregivers of America, will be honored with the AZBio Service Award at the 20th annual AZBio Awards on September 18, 2024 at the Phoenix Convention Center.Continue reading
Valley Fever: Stakeholders Explore Developing Vaccines for Fungal Diseases
The FDA, NIH, and CDC will bring together a diverse group of stakeholders to summarize progress toward developing vaccines against fungal diseases, with an emphasis on our current understanding of the epidemiology, biology, and immunology of Valley feverContinue reading